Rare diseases
Investigational molecules
Locations
Study of the use of tasadenoturev for children and young adults with recurrent or resistant high-grade brain tumors
SpainA study of pumitamig and a drug combination versus nivolumab and a drug combination for patients with untreated advanced or metastatic stomach or esophageal cancer
SpainA study of pumitamig and a drug combination versus bevacizumab and a drug combination for patients with untreated, unresectable, or metastatic colorectal cancer
SpainA study of the humanised IgG1 lalaps-yte monoclonal antibody against lysophosphatidic acid receptor 1 to treat adults with idiopathic pulmonary fibrosis
SpainA study to compare glofitamab against a drug combination for patients with relapsed or refractory mantle cell lymphoma
SpainA study of JNJ-78278343 and docetaxel compared to docetaxel and prednisone in patients with metastatic castration-resistant prostate cancer
SpainA Phase 3 study to evaluate the efficacy and safety of ION582 in children and adults with Angelman syndrome
SpainA study evaluating the efficacy and safety of inavolisib and enzalutamide in patients with metastatic castration-resistant prostate cancer
SpainStudy of AMO959, lutetium (177Lu) vipivotide tetraxetan, and a drug combination for adults with advanced prostate cancer.
SpainComparing the effectiveness of 7 days versus 14 days of ciprofloxacin or ceftriaxone for treating kidney infection in kidney transplant recipients
SpainA safety and efficacy study of SAR445399 in adults with moderate to severe hidradenitis suppurativa
SpainA study to evaluate the effectiveness of BI 1015550 in people with lung abnormalities and a family history of pulmonary fibrosis
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
